Charcot–Marie–Tooth disease and neuroinflammation
- 28 January 2020
- journal article
- Published by Wiley in Clinical and Experimental Neuroimmunology
- Vol. 11 (2) , 109-116
Abstract
Patients with the misdiagnosis or co‐occurrence of Charcot–Marie–Tooth disease (CMT) and inflammatory neuropathies have been reported previously. Both CMT and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have similar clinical features, including flaccid weakness in four limbs with areflexia, demyelinating neurophysiological features and pathological demyelination. However, the symptoms of CIDP progress for several weeks or months, and typical CIDP shows proximal and distal muscle weakness. In contrast, CMT progresses for several decades and presents distal‐dominant muscle weakness, which is called length‐dependent neuropathy. On neurophysiological evaluation, CMT had been considered to show “uniform conduction slowing.” However, a recent study showed that CMT could show non‐uniform conduction abnormalities, which resemble inflammatory neuropathies. Furthermore, the incidence of inflammatory neuropathy in CMT is estimated to be higher than that in the general population. CMT1A with CIDP was the most common, followed by CMTX1 with CIDP and CMT1A with Guillain–Barré syndrome. Some patients showed macrophage‐associated demyelination or mononuclear cell infiltrations in their nerves. Most patients responded to immune therapies at least partly. The pathophysiology in such patients has not yet been elucidated. However, the involvement of the immune system in the development of demyelination in CMT was established by experimental animal studies, and vulnerability to immune abnormalities is suggested in abnormal myelin.Keywords
This publication has 39 references indexed in Scilit:
- Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathyMuscle & Nerve, 2016
- CIDP diagnostic pitfalls and perception of treatment benefitNeurology, 2015
- Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatmentNeurology, 2012
- Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P2 phosphatase FIG4Brain, 2011
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First RevisionEuropean Journal of Neurology, 2010
- Demyelinating X-linked Charcot-Marie-Tooth disease: Unusual electrophysiological findingsMuscle & Nerve, 1999
- Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndromeMuscle & Nerve, 1999
- Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D)Human Molecular Genetics, 1996
- Uniform slowing of conduction velocities in Charcot‐Marie‐Tooth polyneuropathy type 1Neurology, 1993
- The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathiesNeurology, 1982